A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...
A previously "hidden" subtype of Multiple Sclerosis (MS)—a condition that affects the brain and spinal cord—has been uncovered. The distinct subtype exhibits "significant cognitive deficits with ...
Multiple sclerosis (MS [MIM 126200]) is a neurodegenerative autoimmune disease characterized by demyelination within the central nervous system (CNS). Demyelination and the resulting formation of scar ...
Multiple sclerosis (MS) is a debilitating neuroimmunological and neurodegenerative disease (MS [MIM 126200]) and is estimated to affect 400 000 individuals in the United States alone. Numerous ...
Multiple sclerosis diagnosed in people under 18 is called pediatric MS or pediatric-onset multiple sclerosis (POMS). It’s associated with more frequent relapses but a slower accumulation of disability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback